Transcranial magnetic stimulation in the treatment of depression.
By A. Gershon, P. Dannon, L. Grunhaus. American Journal of Psychiatry, 2003
645 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Neurology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/b9389fdf537455ec04ec2d974a5db57a96e4b58d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
- Alvaro Pascual-Leone
- Friedhelm Christoph Hummel
- Felipe Fregni
- John C. Rothwell
- Hartwig Roman Siebner
- C. J. Stagg
- Ulf Ziemann
- Andrea Antal
In Neurology
- Alvaro Pascual-Leone
- Felipe Fregni
- John C. Rothwell
- Friedhelm Christoph Hummel
- Hartwig Roman Siebner
- Ulf Ziemann
- Walter Paulus
- C. J. Stagg
In Psychiatry and Mental health
Citations in the corpus
- Transcranial direct current stimulation: A computer-based human model study (2007, background): “The leading hypothesis to account for the antidepressant effects of rTMS (see review, Gershon et al., 2003) is that when high-frequency rTMS, which has been shown to increase cortical excitability, is applied to the left DLPFC it can normalize a pathological state of hypoactivity in depressed…”
- Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). (2014, positive): “Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefron”
- Multiple-Color Optical Activation, Silencing, and Desynchronization of Neural Activity, with Single-Spike Temporal Resolution (2007, neutral): “, [12–17]).”
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “…if a seasonal component is involved) (Poon et al., 2012), vagus nerve stimulation (Rizvi et al., 2011) and repeated transcranial magnetic stimulation (George, 2010) should all be reserved for specialist centres and patients need to be monitored medically and for the emergence of manic switches.”
- Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research (2009, background): “…relations and the pathophysiology of various neurologic and psychiatric disorders (Wassermannn and Lisanby, 2001; Kobayashi and Pascual-Leone, 2003; Gershon et al., 2003; Tassinari et al., 2003; Rossi and Rossini, 2004; Leafaucheur, 2004; Hoffman et al., 2005; Couturier, 2005; Fregni et al.,…”